Paris, France

Raffaello Paolini

This inventor holds 1 USPTO granted patent. Top assignee: Regulaxis. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raffaello Paolini. Retrieved from https://idiyas.com/inventor/raffaello-paolini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raffaello Paolini and His Osteoarthritis Treatment Patent

Introduction

Raffaello Paolini is an inventor associated with Paris, France, and the biotechnology company Regulaxis. His patent work focuses on a peptide-based approach to treating osteoarthritis.

Latest Patents

Paolini is listed as an inventor on 1 patent: “Methods for Treating Osteoarthritis by Administering Linked Variants of Growth Hormone and Somatostatin.” The disclosure describes peptides that include the sequence SEQ ID NO: 1 for use in treating osteoarthritis.

Career Highlights

Paolini’s listed invention addresses osteoarthritis through the administration of linked variants of growth hormone and somatostatin. The patent connects his work with research and development at Regulaxis.

Collaborations

Paolini’s listed coworkers include Claude Carelli and Christelle Vêtu.

Conclusion

Raffaello Paolini’s patent record highlights his contribution to research into peptide-based approaches for osteoarthritis treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…